Ralph Lauren Free cash flow increased by 1834.0% to $704.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $677.20M to $704.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $219.40M | $181.40M | $307.30M | $5.90M | -$87.90M | $323.10M | $231.10M | $30.10M | $562.60M | $81.10M | $243.90M | $55.50M | $677.20M | $42.30M | -$11.20M | -$40.60M | $704.00M |
| QoQ Change | — | -17.3% | +69.4% | -98.1% | <-999% | +467.6% | -28.5% | -87.0% | >999% | -85.6% | +200.7% | -77.2% | >999% | -93.8% | -126.5% | -262.5% | >999% |
| YoY Change | — | — | — | -97.3% | -148.5% | +5.1% | >999% | +134.2% | +74.1% | — | +5.5% | +84.4% | +20.4% | -47.8% | -104.6% | -173.2% | +4.0% |